Des and Cancer of Vagina/Cervix - Collaborative Studies

Herbst, Arthur L.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 3U01CA062912-01S1
• Application #: 3550236
• Study Section: Special Emphasis Panel (SRC (80))
• Project Start: 1993-09-30
• Project End: 1997-09-29
• Budget Start: 1993-09-30
• Budget End: 1994-09-29
• Support Year: 1
• Fiscal Year: 1994

Institution

• Name: University of Chicago
• Type: Schools of Medicine
• DUNS #: 225410919
• City: Chicago
• State: IL
• Country: United States
• Zip Code: 60637

Publications

Palmer, J R; Anderson, D; Helmrich, S P et al. (2000) Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma. Obstet Gynecol 95:814-20

Herbst, A L (2000) Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Gynecol Oncol 76:147-56

Waggoner, S E; Baunoch, D A; Anderson, S A et al. (1998) Bcl-2 protein expression associated with resistance to apoptosis in clear cell adenocarcinomas of the vagina and cervix expressing wild-type p53. Ann Surg Oncol 5:544-7

Waggoner, S E; Anderson, S M; Luce, M C et al. (1996) p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol 60:339-44

Waggoner, S E; Mittendorf, R; Biney, N et al. (1994) Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol 55:238-44